No CrossRef data available.
Article contents
Inhaled Loxapine for the Acute Treatment of Agitation: Clinical Experience
Published online by Cambridge University Press: 15 April 2020
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction
Agitation (excessive motor or verbal activity) can be associatedoften with schizophrenia or bipolar mania, and further escalate intoaggressive behavior and potentially lead to injuries in patients andstaff. A new drug is available for the acute treatment, inhaledloxapine that allows for direct administration to the lungs, resulting in rapid absorption into the systemic circulation and rapidtranquilization.
Objective
Presenting the clinical experience with Inhaled Loxapine in thetreatment of agitation.
Results
We haveselected representative cases of patients with a psychiatricpathology, from emergency / acute unit, characterizing theircircumstances of current admission, the intensity and the evolutionof the episodes, to evaluate the applicability and practical pointsarising from the clinical experience.
Conclusion
Inthe era of evidence-based practice each case report for the realclinical life adds valuable new information to the medical knowledgeof new options of treatment.
- Type
- Article: 1924
- Information
- European Psychiatry , Volume 30 , Issue S1: Abstracts of the 23rd European Congress of Psychiatry , March 2015 , pp. 1
- Copyright
- Copyright © European Psychiatric Association 2015
You have
Access
Comments
No Comments have been published for this article.